pyrroles has been researched along with Lipoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, DJ; Bartholomew, PM; Koza-Taylor, P; Nambiar, P; Papanikolaou, A; Radi, ZA; Vogel, WM; Wisialowski, T | 1 |
| Bartholomew, P; Elwell, M; Radi, Z; Vogel, WM | 1 |
1 review(s) available for pyrroles and Lipoma
| Article | Year |
|---|---|
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
Topics: Animals; Benzazepines; Carcinogenicity Tests; Disease Models, Animal; Humans; Hydromorphone; Lipoma; Mutagenicity Tests; Neoplasms; Phentolamine; Piperidines; Pyrimidines; Pyrroles; Quinoxalines; Rats; Risk Assessment; Varenicline | 2013 |
1 other study(ies) available for pyrroles and Lipoma
| Article | Year |
|---|---|
Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.
Topics: Adipose Tissue, Brown; Animals; Blood Pressure; Cell Proliferation; Female; Heart Rate; Janus Kinase Inhibitors; Lipoma; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT Transcription Factors; Trans-Activators | 2017 |